Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tetratricopeptide repeat domain 7B pseudogene (ENSG00000258930) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a gene but non-functional due to mutations that prevent its proper transcription or translation. Pseudogenes are generally regarded as non-coding elements, though some may retain the capability for transcription without producing functional protein products. The parent gene, TTC7B, encodes a member of the tetratricopeptide repeat (TPR) protein family, which in functional forms participate in protein-protein interactions and scaffolding complexes, but the pseudogene itself lacks such roles[2][3][5]. There is no scientific evidence indicating that this pseudogene fulfills any biological, therapeutic, or clinical biomarker function.
None (Not targeted by any therapeutic agents)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 7B pseudogene.